# Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

> **NCT03168815** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 98 (estimated)

## Conditions studied

- Immunocompromised
- Hematologic Malignancy
- Post Hematopoietic Stem Cell Transplant
- Hypoxia
- Pulmonary Infiltrates

## Interventions

- **DEVICE:** High Flow Nasal Cannula or Low Flow Nasal Cannula

## Key facts

- **NCT ID:** NCT03168815
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-01-10
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2025-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168815, "Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03168815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*